Диссертация (1173229), страница 27
Текст из файла (страница 27)
Surg., 2014, Vol. 52, № 4, Р. 308 – 313.351. Rosenstein E.D., Greenwald R.A., Kushner L.J., Weissmann G. Hypothesis:the humoral immune response to oral bacteria provides a* stimulus for the development of rheumatoid arthritis // Inflammation, 2004, Vol.
28, №6, P. 311 – 318.352. Rosenstein E.D., Kushner L.J., Kramer N., Kazandjian G. Pilot study of dietary fatty acid supplementation in the treatment of adult periodontitis // Prostaglandins Leukot Essent Fatty Acids, 2003, Vol. 68, № 3, P. 213 – 218.353. RizzoA., PaolilloR., GuidaL. etal.Effectofmetronidazoleand modulation of cytokine production on human periodontal ligament cells // Int.Immunopharmacol., 2010, Vol. 10, № 7, Р. 744 – 750.354.
Salvi G.E., Lang N.P. Host response modulation in the management of peri-151odontal diseases // J. Clin. Periodont., 2005, Vol. 32, Р. 108 – 129.355. Scardina G.A., Messina P. Microvascular periodontal alterations: A possiblerelationship between periodontitis and rheumatoid arthritis // Clin. Hemorheol.Microcirc., 2007, Vol. 37, № 3, P. 229 – 235.356.
Scutellari P.N. The temporomandibular joint in pathologic conditions:rheumatoid arthritis and seronegative spondyloarthritis // Radiol. Med., 1993, Vol.86, № 4, P. 456 – 466.357. Sekar S., Murugan T. Host modulation by therapeutic agents // J. Pharm.Bioallied Sci., 2012, Vol. 4, Suppl. 2, Р. S256 – 259.358. Serhan C.N., Jain A., Marleau S. et al. Reduced inflammation and tissuedamage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators // J. Immunol., 2003, Vol.
171, Р. 6856 – 6865.359. Shetty S., Bose A., Sridharan S., Satyanarayana A., Rahul A. A clinicobiochemical evaluation of the role of a herbal (Ayurvedic) immunomodulator inchronic periodontal disease: a pilot study // Oral Health Dent. Manag., 2013, Vol.12, № 2, Р. 95 – 104.360. Silvestre-Rangil J., Bagán L., Silvestre F.J., Martinez-Herrera M., Bagán J.Periodontal, salivary and IL-6 status in rheumatoid arthritis patients. A crosssectional study // Med. Oral. Patol.
Oral. Cir. Bucal., 2017, Vol. 1; 22(5), e595e600.361. Strand V., Kimberly R., Isaacs J.D. Biologic therapies in rheumatology: lessons learned, future directions // Nat. Rev. Drug. Discov., 2007, Vol. 6, P. 75 – 92.362. Sundararaj S.C., Thomas M.V., Peyyala R., Dziubla T.D., Puleo D.A.
Design of a multiple drug delivery system directed at periodontitis // Biomaterials, 2013, Vol. 34, № 34, P. 8835 – 8842.363. Szwarc M.M. et al. Aberrant activation of the RANK signaling receptor induces murine salivary gland tumors // PLoS ONE, 2015, Vol. 10, № 6, Режимдоступа: doi:10.1371 / journal.pone.0128467.364. Taba M.Jr., Souza S.L., Mariguela V.C. Periodontal disease: a genetic per-152spective // Braz. Oral Res., 2012, Vol. 26, Suppl. 1, Р. 32 – 38.365. Tang K.S.
Expression of osteoprotegerin (OPG) and receptor activator ofnuclear factor–кB Ligand (RANKL) on root surface after different extra-oral drytimes // Leeds, 2012, 125 p.366. Tang Q., Fu H., Qin B. et al. A possible link between rheumatoid arthritisand periodontitis: a systematic review and meta-analysis // Int. J. Periodont.Restor. Dent., 2017, Vol.
37, № 1, P. 79 – 86.367. Tegelberg A. A 3-year follow-up of temporomandibular disorders in rheumatoid arthritis and ankylosing spondylitis //Acta. Odontol. Scand., 1996, Vol. 54,№ 1, P. 14 – 18.368. Thou J., Ebersole J.L. Rheumatoid factor (RF) distribution in periodontaldisease // Ill. Clin. Immunol., 1991, Vol.
11, № 3, P. 132 – 142.369. Thou J., Ebersole J.L. Rheumatoid factor from periodontitis patients crossreacts with epitopes on oral bacteria // Oral Dis., 1996, Vol. 2, № 4, P. 253 – 262.370. Tindle D., Murdoch-Kinch C.A. Dental management of patients taking oral bisphosphonates and other antiresorptive agents // J. Mich. Dent.Assoc., 2013, Vol. 95, № 8, Р. 40 – 42.371. Tornero M.J., Ballina García F.J., Calvo Alén J., Caracuel Ruiz M.Á. et al.Recommendations for the use of methotrexate in rheumatoid arthritis: up and downscaling of the dose and administration routes // Reumatol.
Clin., 2015, Vol. 11(1),P. 3 – 8.372. Treister N., Glick M. Rheumatoid arthritis: a review and suggested dentalcare considerations // J. Am. Dent. Assoc., 1999, Vol. 130, № 5, P. 689 – 698.373. Ulmner M., Jarnbring F., Törring O. Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate // J. Oral. Maxillofac.
Surg., 2014,Vol. 72, 1, Р. 76 – 82.374. Üstün K., Erciyas K., Kısacık B. et al. Host modulation in rheumatoid arthritis patients with TNF blockers significantly decreases biochemical parametersin periodontitis // Inflammation, 2013, Vol. 36, № 5, P. 1171 – 1177.153375. Utreja A., Almas K., Javed F. Dental extraction as a risk factor for bisphosphonate related osteonecrosis of the jaw in cancer patients: an update //Odontostomatol. Trop., 2013, Vol. 36, № 142, Р. 38 – 46.376. Uyanne J., Calhoun C.C., Le A.D. Antiresorptive drug-related osteonecrosisof the jaw // Dent. Clin. North.
Am., 2014, Vol., № 2, Р. 369 – 384.377. Verbeke F. et al. Peptides as quorum sensing molecules: measurement techniques and obtained levels in vitro and in vivo // Front. Neurosc., 2017, Vol. 11, Р.183 – 200.378. Vermeer J.A., Jansen I.D., Marthi M. et al. Jaw bone marrow-derived osteoclast precursors internalize more bisphosphonate than long-bone marrow precursors // Bone, 2013, Vol.
57, № 1, P. 242 – 251.379. Walker C., Preshaw P.M., Novak J. et al. Long-term treatment with subantimicrobial dose doxycycline has no antibacterial effect on intestinal flora // J.Clin. Periodont., 2005, Vol. 32, P. 1163 – 1169.380. Walker C., Thomas J., Nango S., Lennon J., Wetzel J., Powala C. Long-termtreatment with sub-antimicrobial dose doxycycline exerts no antibacterial effect onthe subgingival microflora associated with adult periodontitis // J. Periodontol.,2000, Vol. 71, P. 1465 – 1471.381. Wasilewska A., Rybi-Szuminska A., Zoch-Zwierz W.
Serum RANKL,osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children // Pediatr.Nephrol., 2010, Vol. 25(10), P. 2067–2075.382. Wegner N. et al. Autoimmunity to specific citrullinated proteins gives thefirst clues to the etiology of rheumatoid arthritis // Immunol. Rev., 2010, Vol. 233,№ 1, Р. 35 – 54.383. Williams R.C. Periodontal disease // N. Engl.
J. Med., 1990, Vol. 8, №322(6), Р. 373 – 382.384. Wysowski D.K., Greene P. Trends in osteoporosis treatment with oral andintravenous bisphosphonates in the United States, 2002-2012 // Bone, 2013, Vol.57, № 2, P. 423 – 428.154385. Yang N.Y., Wang C.Y., Chyuan I.T., Wu K.J., et al. Significant associationof rheumatoid arthritis-related inflammatory markers with non-surgical periodontaltherapy // J. Formos. Med. Assoc., 2018, Vol.
117(11), P. 1003 – 1010.386. Yusof Z., Porter S.R., Greenman J., Scully С. Levels of serum IgG againstPorphyromonas gingivalis in patients with rapidly progressive periodontitis, rheumatoid arthritis and adult periodontitis // Nihon. Univ. Sch. Dent., 1995, Vol. 37,№ 4, P. 197 – 200.387.
Zaman M.U., Nakamoto T., Tanimoto K. A retrospective study of digitalsubtraction technique to detect sclerotic changes in alveolar bone on intraoral radiographs of bisphosphonate-treated patients // Dentomaxillofac. Radiоl., 2013, Vol.42, № 10, р. 242.388. Zhang X. et al. The oral and gut microbiomes are perturbed in rheumatoidarthritis and partly normalized after treatment // Nature Medicine., 2015, Vol. 21,№ 8, P. 895 – 905.389. Zhang D.Z., Zhong D.Y., Deng J., Wang J.B. Relationship between periodontal disease and rheumatoid arthritis // Hua Xi Kou Qiang Yi Xue Za Zhi., 2005,Vol.
23, № 6, P. 498 – 501.390. Zivkovich S., Markovis D., Petrovis S. Caries incidence in rheumatic patients // Stomatol. Glas. Srb., 1989, Vol. 36, № 3, P. 239 – 247.391. Zuffetti F., Testori T., Capelli M., Rossi M.C., Del Fabbro M.
The topicaladministration of bisphosphonates in implant surgery: a randomized splitmouthprospective study with a follow-up up to 5 years // Clin. Implant. Dent.Relat. Res., 2013, Vol. 20, Р. 152 – 156.392. Zustin J., Reske D., Zrnc T.A. et al. Pseudoepitheliomatous hyperplasia associated with bisphosphonate-related osteonecrosis of the jaw // In Vivo, 2014,Vol.
28, № 1, Р. 125 – 131..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
